$500 – $1,000 Paid Clinical Trials
440 studies
Short outpatient Phase 1 studies and multi-visit observational studies often compensate in the $500–$1,000 range.
Compensation amounts shown are typical ranges for this study type — not guaranteed amounts. Actual compensation is set by each study sponsor and documented in the informed consent form. ClinicalTrials.gov does not include a structured compensation field.
Showing 41–60 of 440 studies
Recruiting
Phase 1
A Research Study Investigating the Effect of NNC0497-0040 in Healthy Participants, Participants With Overweight or Obesity, and Participants With Type 1 Diabetes With Overweight or Obesity
ObesityHealthy VolunteersOverweight+1 more
Novo Nordisk A/S146 enrolled1 locationNCT07578584
Recruiting
Phase 1
A Study to Evaluate Dermal Open-Flow Microperfusion and Plasma Pharmacokinetic Study of Multiple Doses of Oral Povorcitinib or Topical Ruxolitinib Cream in Healthy Adult Participants
Healthy Participants
Incyte Corporation24 enrolled1 locationNCT07588139
Recruiting
Phase 1
A Clinical Trial in Healthy Participants to Study the Effect of a Single Dose of MK-8527 on Levels of Methadone (MK-8527-020)
Healthy
Merck Sharp & Dohme LLC14 enrolled1 locationNCT07528508
Recruiting
Phase 1
Assessment of Neuroinflammation in Central Inflammatory Disorders Using [F-18]DPA-714.
Chronic Fatigue SyndromeHealthyMultiple Sclerosis+1 more
University of Alabama at Birmingham120 enrolled1 locationNCT03759522
Recruiting
Phase 1
A Mass Balance Study of Oral [14C] ABBV-932 in Healthy Adult Male Participants
Healthy Volunteer
AbbVie8 enrolled1 locationNCT06953934
Recruiting
Phase 1
Role of Metal Ion Transporter ZIP8 in Alcohol-Related Behaviors
Healthy Volunteer
National Institute on Alcohol Abuse and Alcoholism (NIAAA)50 enrolled1 locationNCT06819189
Recruiting
Phase 1
A Study to Evaluate Safety, Tolerability, and Immunogenicity of V350A and V350B in Healthy Participants (V350-001).
Healthy
Merck Sharp & Dohme LLC250 enrolled9 locationsNCT06655324
Recruiting
Phase 1
Bioequivalence (BE) Study Between YHP2511 and YHP2511A in Healthy Volunteers
Healthy Subjects
Yuhan Corporation60 enrolled1 locationNCT07470125
Recruiting
Phase 1
Safety and Tolerability of ZE74-0282 in Healthy Volunteers
Healthy Volunteers
Eilean Therapeutics AU Pty Ltd40 enrolled1 locationNCT07527221
Recruiting
Phase 1
Hormones, Outcomes, and Pain Pathways in Exercise Study
Activity, MotorInflammationChest Pain+10 more
University of Houston140 enrolled1 locationNCT07579182
Recruiting
Phase 1
A Study to Investigate Safety, Tolerability, and Pharmacokinetics of AZD3974 in Healthy Participants
Healthy Participants
AstraZeneca176 enrolled2 locationsNCT07290283
Recruiting
Phase 1
Graded Insulin Suppression Test P&F
ObesityInsulin ResistanceHealthy+1 more
Columbia University15 enrolled1 locationNCT06592261
Recruiting
Phase 1
The Effects of Dietary Supplementation on Serum Protein Glycosylation
Healthy
University of California, Davis44 enrolled1 locationNCT05040204
Recruiting
Phase 1
A Trial to Assess Safety, Tolerability, and Pharmacokinetics of AN01 Inhalation Powder in Healthy Participants
Healthy VolunteerHealthy Participants Study
AirNexis Therapeutics, Inc.24 enrolled1 locationNCT07554365
Recruiting
Phase 1
A Study to Test How Different Doses of BI 3814916 Are Tolerated by Healthy People
Healthy
Boehringer Ingelheim136 enrolled1 locationNCT07486115
Recruiting
Phase 1
A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Single Ascending Doses of ABBV-1451 Infusions and Injections in Healthy Adult Participants
Healthy Volunteer
AbbVie90 enrolled1 locationNCT07570147
Recruiting
Phase 1
A First-in-Human Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Single and Multiple Oral Doses of Debio 1453P in Healthy Adults
Healthy Participants
Debiopharm International SA88 enrolled1 locationNCT07035769
Recruiting
Phase 1
A Study to Learn How a Single Dose of the Study Medicine Called PF-08057418 is Tolerated in the Body of Healthy Adults.
Healthy
Pfizer8 enrolled1 locationNCT07575906
Recruiting
Phase 1
A Dose-Escalation Study of RO7875913 in Healthy Participants
Healthy Volunteers
Genentech, Inc.40 enrolled1 locationNCT07342114
Recruiting
Phase 1
A Study to Learn How the Body Processes the Study Medicine PF-07328948 in People With and Without Reduced Liver Function
HealthyHepatic Impairment
Pfizer26 enrolled3 locationsNCT07269301